CLSI EP14-A3

Evaluation of Commutability of Processed Samples; Approved Guideline, Third Edition, EP14A3E
standard by Clinical and Laboratory Standards Institute, 08/15/2014

CLSI I/LA26-A2 (R2018)

Performance of Single Cell Immune Response Assays; Approved Guideline – Second Edition, ILA26A2E
standard by Clinical and Laboratory Standards Institute, 11/01/2013

CLSI M47-A

Principles and Procedures for Blood Cultures; Approved Guideline, M47AE
standard by Clinical and Laboratory Standards Institute, 05/01/2007

CLSI M43-A

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE
standard by Clinical and Laboratory Standards Institute, 10/01/2011

CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1E
standard by Clinical and Laboratory Standards Institute, 12/01/2015

CLSI GP16-A3 (R2018)

Urinalysis; Approved Guideline–Third Edition, GP16A3
standard by Clinical and Laboratory Standards Institute, 02/01/2009

CLSI M26-A

Methods for Determining Bacterial Activity of Antimicrobial Agents; Approved Guideline, M26AE
standard by Clinical and Laboratory Standards Institute, 01/01/1999

CLSI M02-A12, M07-A10, M100-S27 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Twelfth Edition / Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Tenth Edition / Performance Standards for Antimicrobial Susceptibility Testing,
standard by Clinical and Laboratory Standards Institute, 01/01/2017

CLSI H21-A5

Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; Approved Guideline, Fifth Edition, H21-A5
standard by Clinical and Laboratory Standards Institute, 01/01/2008

CLSI M24

Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 3rd Edition, M24Ed3E
standard by Clinical and Laboratory Standards Institute, 11/01/2018